Neurochemical markers | FRL | FSL |
---|
control | control | passive fluoxetine |
---|
5-HIAA (ng/g) | 105.2 ± 16.4 | 95.06 ± 28.81 | 95.88 ± 11.90 |
5-HT (ng/g) | 33.28 ± 5.40 | 34.07 ± 4.01 | 34.67 ± 2.86 |
GSH (µg/g) | 32.62 ± 7.07 | 25.54 ± 5.92a) | 18.22 ± 6.75b) |
GSSG (µg/g) | 163.30 ± 77.44 | 338.80 ± 106.7a) | 384.10 ± 141.00b) |
- Limits of detection were 3.90 ng/ml (5-HIAA and 5-HT), 0.31 µg/g (GSH) and 0.62 µg/g (GSSG). Final concentrations are expressed as w/w due to brain tissue being the sample matrix. The values used for calculations of the ratios are presented here as mean ± SD (n = 16 per group)
- a)statistically different (p < 0.05), compared to FRL control group
- b)statistically different (p < 0.05), compared to FSL fluoxetine group
- 5-HIAA 5-hydroxyindoleacetic acid. 5-HT 5-hydroxytryptamine. GSH Glutathione. GSSG glutathione disulphide